NARA Discovery
Article Details
← Back to Search Results
Journal Article

The genome analysis of C andidatus B urkholderia crenata reveals that secondary metabolism may be a key function of the A rdisia crenata leaf nodule symbiosis

Aurelien Carlier; Linda Fehr; Marta Pinto‐Carbó; Till Schäberle; Raphael Reher; Steven Dessein; Gabriele König; Leo Eberl
Environmental Microbiology · Vol. 18, Issue 8 · pp. 2507-2522 · 2016

Abstract

Summary A majority of A rdisia species harbour B urkholderia sp. bacteria within specialized leaf nodules. The bacteria are transmitted hereditarily and have not yet been cultured outside of their host. Because the plants cannot develop beyond the seedling stage without their symbionts, the symbiosis is considered obligatory. We sequenced for the first time the genome of C andidatus B urkholderia crenata ( C a. B . crenata), the leaf nodule symbiont of A rdisia crenata . The genome of C a. B . crenata is the smallest B urkholderia genome to date. It contains a large amount of insertion sequences and pseudogenes and displays features consistent with reductive genome evolution. The genome does not encode functions commonly associated with plant symbioses such as nitrogen fixation and plant hormone metabolism. However, we identified unique genes with a predicted role in secondary metabolism in the genome of C a . B . crenata. Specifically, we provide evidence that the bacterial symbionts are responsible for the synthesis of compound FR 900359, a cyclic depsipeptide with biomedical properties previously isolated from leaves of A . crenata .

Bibliographic Information

JournalEnvironmental Microbiology
PublisherWiley
Publication Date2016-09-01
Publication Year2016
Volume18
Issue8
Pages2507-2522
Document TypeJournal Article
Print ISSN1462-2912
eISSN1462-2920
DOI10.1111/1462-2920.13184
SubjectMicrobial Ecology

Access Information

NARA Access Coverage1999-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/14622920
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.